Food and Drug Administration (FDA), at an afternoon news conference. is one of three so-called erythropoiesis-stimulating agents (ESAs) manufactured by Amgen (the other two are.    From Wordnik.com.  [Medlogs - Recent stories] Reference

A flurry of new guidelines and rules regarding erythropoiesis stimulating agents.    From Wordnik.com.  [Archive 2007-05-01] Reference

Recently, various Government agencies have been very active in regulating the use of erythropoiesis stimulating agents ESAs.    From Wordnik.com.  [MEDICARE taketh away and giveth back -sorta] Reference

CMS has issued draft guidelines regarding the use of erythropoiesis stimulating agents ESAs that are certain to cause worry among patients, oncologists and kidney doctors.    From Wordnik.com.  [Archive 2007-05-01] Reference

PLCγ1 deletion results in reduced vasculogenesis and erythropoiesis in mice.    From Wordnik.com.  [PLoS ONE Alerts: New Articles] Reference

Physiological reserve capacity for erythropoiesis and leucopoiesis is reduced.    From Wordnik.com.  [Recently Uploaded Slideshows] Reference

Zon LI (1997) Genetics of erythropoiesis: induced mutations in mice and zebrafish.    From Wordnik.com.  [PLoS ONE Alerts: New Articles] Reference

One treatment strategy is to use erythropoiesis-stimulating agents (ESAs) to increase hemoglobin levels.    From Wordnik.com.  [JAMA current issue] Reference

Safety concerns associated with use of erythropoiesis stimulating agents (ESA) in cancer patients resulted in a.    From Wordnik.com.  [Medindia Health News] Reference

NuPIAO is a highly glycosylated ESA (erythropoiesis-stimulating agent) that requires only once-per-week dosing.    From Wordnik.com.  [Biotech Sector and Stocks Analysis from Seeking Alpha] Reference

The decrease in hemoglobin is related to several factors, including ineffective erythropoiesis and hemodilution.    From Wordnik.com.  [Recently Uploaded Slideshows] Reference

NuPIAO is a highly glycosylated ESA (erythropoiesis-stimulating agent) with extended half-life and increased biologic activity.    From Wordnik.com.  [RedOrbit News - Technology] Reference

For in vitro erythropoiesis many different approaches have been taken, utilizing pluripotent stem cells from a variety of sources.    From Wordnik.com.  [PLoS ONE Alerts: New Articles] Reference

FDA has issued a Public Health Advisory which summarizes several recent safety concerns with the use of erythropoiesis stimulating agents.    From Wordnik.com.  [WN.com - Articles related to M&S selling extra-big school uniforms for obese children] Reference

Here we show that loss of EKLF leads to aberrant entry into S-phase of the cell cycle during both primitive and definitive erythropoiesis.    From Wordnik.com.  [Journal of Biological Chemistry current issue] Reference

If two of the four α loci are affected, alpha thalassemia trait, type 1 erythropoiesis, though there is a mild microcytic hypochromic anemia.    From Wordnik.com.  [Citizendium, the Citizens' Compendium - Recent changes [en]] Reference

FDA has issued a Public Health Advisory which summarizes several recent safety concerns with the use of erythropoiesis stimulating agents (ESAs).    From Wordnik.com.  [WN.com - Articles related to M&S selling extra-big school uniforms for obese children] Reference

The stimulation of erythropoiesis is a rapidly evolving area of research, with mechanistic insights often developing rapidly into therapeutic agents.    From Wordnik.com.  [Naturejobs - All Jobs] Reference

Kidney function, cause of kidney disease, and use of iron supplementation and erythropoiesis-stimulating agents did not appear to explain the racial difference.    From Wordnik.com.  [MedPageToday.com - medical news plus CME for physicians] Reference

Food and Drug Administration (FDA) has approved the Risk Evaluation and Mitigation Strategy (REMS) for erythropoiesis-stimulating agents (ESAs), which include Aranesp®.    From Wordnik.com.  [THE MEDICAL NEWS] Reference

Safety concerns associated with use of erythropoiesis stimulating agents (ESA) in cancer patients resulted in a November 2007 prescribing information black box warning.    From Wordnik.com.  [RedOrbit News - Technology] Reference

Department of Virology, Pasteur Institute, Paris, France The basic mechanisms of stem cell proliferation and differentiation leading to erythropoiesis are well established.    From Wordnik.com.  [PLoS ONE Alerts: New Articles] Reference

Posted on: Wednesday, 11 November 2009, 16: 58 CST Use of erythropoiesis-stimulating agents is associated with an increased risk of venous thromboembolism, according to study.    From Wordnik.com.  [WN.com - Articles related to 'Infertile' mother who didn't know she was pregnant gives birth... after putting weight gain down ...] Reference

Hematide is a novel synthetic, PEGylated peptidic compound that binds to and activates the erythropoietin receptor and thus acts as an erythropoiesis stimulating agent (ESA).    From Wordnik.com.  [BioSpace.com Featured News and Stories] Reference

Explain to patients that intravenous iron supplementation failed to improve response to erythropoiesis-stimulating therapy in cancer patients with chemotherapy-associated anemia.    From Wordnik.com.  [MedPageToday.com - medical news plus CME for physicians] Reference

The U.S. Food and Drug Administration (FDA) today issued a public health advisory outlining new safety information on the use of erythropoiesis-stimulating agents to treat anemia.    From Wordnik.com.  [xml's Blinklist.com] Reference

Retired doc's thoughts: A flurry of new guidelines and rules regarding erythropoiesis stimulating agents.    From Wordnik.com.  [A flurry of new guidelines and rules regarding erythropoiesis stimulating agents] Reference